Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1199951/full |
| _version_ | 1797828881952014336 |
|---|---|
| author | Zhou Guo Jiamin Lin Kai Sun Jiayou Guo Xudong Yao Genchun Wang Liangcai Hou Jingting Xu Jiachao Guo Fengjing Guo |
| author_facet | Zhou Guo Jiamin Lin Kai Sun Jiayou Guo Xudong Yao Genchun Wang Liangcai Hou Jingting Xu Jiachao Guo Fengjing Guo |
| author_sort | Zhou Guo |
| collection | DOAJ |
| first_indexed | 2024-04-09T13:12:38Z |
| format | Article |
| id | doaj.art-a4a1d164e8df4825bcb0fb3238770d98 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-04-09T13:12:38Z |
| publishDate | 2023-05-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-a4a1d164e8df4825bcb0fb3238770d982023-05-12T06:38:35ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-05-011410.3389/fphar.2023.11999511199951Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathwayZhou Guo0Jiamin Lin1Kai Sun2Jiayou Guo3Xudong Yao4Genchun Wang5Liangcai Hou6Jingting Xu7Jiachao Guo8Fengjing Guo9Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaMichigan State University’s Broad College of Business, East Lansing, MI, United StatesDepartment of Orthopedic Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Chinahttps://www.frontiersin.org/articles/10.3389/fphar.2023.1199951/fullosteoarthritischondrocytesferroptosisdeferoxamineNrf2 |
| spellingShingle | Zhou Guo Jiamin Lin Kai Sun Jiayou Guo Xudong Yao Genchun Wang Liangcai Hou Jingting Xu Jiachao Guo Fengjing Guo Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway Frontiers in Pharmacology osteoarthritis chondrocytes ferroptosis deferoxamine Nrf2 |
| title | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_full | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_fullStr | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_full_unstemmed | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_short | Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway |
| title_sort | corrigendum deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the nrf2 pathway |
| topic | osteoarthritis chondrocytes ferroptosis deferoxamine Nrf2 |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1199951/full |
| work_keys_str_mv | AT zhouguo corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT jiaminlin corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT kaisun corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT jiayouguo corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT xudongyao corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT genchunwang corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT liangcaihou corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT jingtingxu corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT jiachaoguo corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway AT fengjingguo corrigendumdeferoxaminealleviatesosteoarthritisbyinhibitingchondrocyteferroptosisandactivatingthenrf2pathway |